Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Trastuzumab 600mg/5ml |
Product Type |
Product Size |
Injection
|
1'S |
Product Company |
Helix pharma
|
100mg/5ml
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Manufacture Deva Holding / Marketed by Searle |
Letrozole 2.5mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Bevacizumab 100mg/4ml |
Product Type |
Product Size |
Capsules |
100'S |
Product Company |
Pharmedic |
Hydroxyurea 500mg |
Product Type |
Product Size |
Tablet |
60'S |
Product Company |
Pharma Solution |
Erlotinib 150mg |
Content | Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. | Etoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors.
| Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon. | "
Bevacizumab, sold under the brand name Avastin among others, is a medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. | Hydroxyurea is in a class of medications called antimetabolites. Hydroxyurea treats cancer by slowing or stopping the growth of cancer cells in your body. Hydroxyurea treats sickle cell anemia by helping to prevent formation of sickle-shaped red blood cells. | Erlotinib is an EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers. |
Reviews
There are no reviews yet.